Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review

Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review

There has been less volume of literature focusing on the Immune-related Hematological Adverse Drug Events (Hem-irAEs) of Immune Checkpoint Inhibitors (ICPis) in cancer patients. Furthermore, there has been no consensus about the management of hematological toxicity from immunotherapy in the recently...

Full description

Bibliographic Details
Main Authors: Nabil E. Omar, Kareem A. El-Fass, Abdelrahman I. Abushouk, Noha Elbaghdady, Abd Elmonem M. Barakat, Ahmed E. Noreldin, Dina Johar, Mohamed Yassin, Anas Hamad, Shereen Elazzazy, Said Dermime
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
immune-related adverse events
ipilimumab
pembrolizumab
nivolumab
atezolizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.01354/full

Similar Items

Similar Items